Modular nanotransporters containing Keap1 monobodies are capable of reducing the toxic effect of acetaminophen on the liver of mice

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Previously, we created a modular nanotransporter (MNT) containing a monobody to Keap1, an intracellular protein inhibitor of the Nrf2 transcription factor that controls cellular protection from oxidative stress and is capable of interacting with Keap1 in hepatocytes and protect this cells from the effects of hydrogen peroxide. Oxidative liver damage by acetaminophen was used as a model to study the antitoxic effect of this MNT. Intraperitoneal injection of acetaminophen to mice resulted in an increase in the level of alanine aminotransferase and aspartate aminotransferase in the blood, as well as in liver edema. A significant decrease in the level of these enzymes in the blood, along with a decrease in liver edema, was observed after preliminary intravenous administration of MNT 2 hours before the acetaminophen injection. The results obtained can serve as a basis for creating drugs aimed at treating diseases associated with oxidative stress.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Y. Khramtsov

Institute of Gene Biology, RAS

Хат алмасуға жауапты Автор.
Email: alsobolev@yandex.ru
Ресей, Moscow

A. Rosenkranz

Institute of Gene Biology, RAS; Lomonosov Moscow State University Moscow

Email: alsobolev@yandex.ru
Ресей, Moscow; Moscow

A. Ulasov

Institute of Gene Biology, RAS

Email: alsobolev@yandex.ru
Ресей, Moscow

T. Slastnikova

Institute of Gene Biology, RAS

Email: alsobolev@yandex.ru
Ресей, Moscow

T. Lupanova

Institute of Gene Biology, RAS

Email: alsobolev@yandex.ru
Ресей, Moscow

R. Alieva

Institute of Gene Biology, RAS

Email: alsobolev@yandex.ru
Ресей, Moscow

G. Georgiev

Institute of Gene Biology, RAS

Email: alsobolev@yandex.ru

Academician of the RAS

Ресей, Moscow

A. Sobolev

Institute of Gene Biology, RAS; Lomonosov Moscow State University Moscow

Email: alsobolev@yandex.ru
Ресей, Moscow; Moscow

Әдебиет тізімі

  1. Bellezza I., Giambanco I., Minelli A., et al. // Acta Mol. Cell Res. 2018. V. 1865(5). P. 721–733.
  2. Hayes J.D., Dinkova-Kostova A.T. // Trends Biochem. Sci. 2014. V. 39(4). P. 199–218.
  3. Ulasov A.V., Rosenkranz A.A., Georgiev G.P., et al. // Life Sci. 2022. V. 291. 120111.
  4. Robledinos-Anton N., Fernandez-Gines R., Manda G., et al. // Oxid. Med. Cell Longev. 2019. V. 2019. 9372182.
  5. Ngo V., Duennwald M.L. // Antioxidants. (Basel). 2022. V. 11(12).
  6. Taguchi K., Kensler T.W. // Arch. Pharm. Res. 2020. V. 43(3). P. 337–349.
  7. Patra U., Mukhopadhyay U., Sarkar R., et al. // Antivir. Res. 2019. V. 161. P. 53–62.
  8. Olagnier D., Farahani E., Thyrsted J., et al. // Nat. Commun. 2020. V. 11. 4938.
  9. Khramtsov Y.V., Ulasov A.V., Slastnikova T.A., et al. // Pharmaceutics. 2023. V. 15. 2687.
  10. Khramtsov Y.V., Ulasov A.V., Rosenkranz A.A., et al. // Pharmaceutics. 2024. V. 16. 1345.
  11. Lee W.M. // Hepatol. 2017. V. 67. P. 1324–1331.
  12. McGill M.R., Williams C.D., Xie Y., et al. // Toxicol. Appl. Pharmacol. 2012. V. 264. P. 387–394.
  13. Vorobyeva A., Bragina O., Altai M., et al. // Contrast. Media Mol. Imaging. 2018. V. 2018. 6930425.
  14. Steffens M. G., Kranenborg M.H., O.C. Boerman O.C., et al. // Cancer Biother. Radiopharm. 1998. V. 13. P. 133–139.
  15. Ferris T., Carroll L., Jenner S., et al. // J. Labelled Comp Radiopharm. 2021. V. 64. P. 92–108.
  16. Bruinstroop E., van der Spek A.H., Boelen A. // Eur. Thyroid J. 2023. V. 12. e220211.
  17. Dohan O., De la Vieja A., Paroder V., et al. // Endocr. Rev. 2003. V. 24. P. 48–77.
  18. Shen Z., Wang Y., Su Z., et al. // Chem. Biol. Interact. 2018. V. 282. P. 22–28.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу
2. Fig. 1. SPECT/CT image of a C57Black/6J mouse one hour after intravenous administration of 125I-labeled MNT. (a) CT image; (b) SPECT image.

Жүктеу (28KB)
Метадеректер
3. Fig. 2. Dependence of 125I activity for 125I-labeled MNT in the mouse organism on time after its intravenous administration. The activity is taken without taking into account the thyroid gland, urinary bladder and stomach. The activity immediately after the administration of 125I-MNT is taken as 100%. The approximation of the data by an exponential dependence is shown.

Жүктеу (18KB)
Метадеректер

© Russian Academy of Sciences, 2025